TU Dresden researchers develop highly innovative solutions for the detection of viral pathogens

The outbreak of the COVID pandemic in 2020 has once again shown how important reliable and rapid detection methods are to initiate effective measures to combat a pandemic. Scientists from the Chair of Materials Science and Nanotechnology at TU Dresden (TUD) have made considerable progress in the development of highly innovative solutions for the detection of viral pathogens in two studies they presented recently. The results of their work have now been published in the journals "ACS Applied Materials & Interfaces" and "Advanced Materials Interfaces".

Customized, powerful and adaptable nanoelectronic sensors represent a promising approach to be ready to fight both current and future pandemics. These sensors not only enable conventional diagnosis in cases of suspected outbreaks, but also a continuous monitoring of ambient air in buses, trains, schools or healthcare facilities. This means that appropriate and immediate measures can be taken as soon viruses appear.

Since 2020, the Dresden scientists have been working intensively on the development of miniaturized sensors for the accurate and efficient detection of SARS-CoV-2 antigens. In addition to the TUD team led by Prof. Gianaurelio Cuniberti and Dr. Bergoi Ibarlucea, scientists from the European Molecular Biology Laboratory (EMBL) in Hamburg, the Leibniz Institute of Polymer Research (IPF) Dresden and the Pohang University of Science and Technology (POSTECH) in Korea were also involved in the two studies.

Sybodies: a revolution in biological recognition

The first study, published in the journal ACS Applied Materials & Interfaces, describes a groundbreaking innovative approach that significantly increases accuracy and speed of SARS-CoV-2 antigen detection. It involves inserting synthetic nanobodies, known as sybodies, into biosensors as receptors.

"Sybodies represent a rapid, sustainable and ethically sound alternative that, unlike conventional antibodies, is developed and manufactured using non-animal methods," said Prof. Gianaurelio Cuniberti, who coordinated both studies with Dr. Bergoi Ibarlucea. "Another key advantage of using sybodies is their smaller size compared to antibodies, so biological recognition processes can take place much closer to the sensor surface, increasing signal strength and making the sensors much faster and more sensitive," he adds. Initial tests have been successfully conducted with silicon nanowire-based field-effect transistors modified with sybodies, demonstrating the great application potential of this approach.

Overcoming the loss of sensitivity in biological fluids

In another paper published in the journal Advanced Materials Interfaces, the team is looking at increasing the sensitivity of the sensors when they operate in biological fluids. Such samples have a complex molecular composition, which severely limits the sensor's detection range. To solve this problem, the scientists developed a special surface modification with a hydrogel based on the dielectric polymer polyethylene glycol. This allows measurements to be taken directly in saliva and other samples from patients, and eliminates the need for time-consuming and costly sample preparation steps.

Source:
Journal references:
  • Zhang, C., et al. (2023). Sybodies as Novel Bioreceptors toward Field-Effect Transistor-Based Detection of SARS-CoV-2 Antigens. ACS Applied Materials & Interfaces. doi.org/10.1021/acsami.3c06073.
  • Parichenko, A., et al., Bergoi Ibarlucea, & Gianaurelio Cuniberti. (2023). Hydrogel‐Gated Silicon Nanotransistors for SARS‐CoV‐2 Antigen Detection in Physiological Ionic Strength. Advanced Materials Interfaces. doi.org/10.1002/admi.202300391.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
SARS-CoV-2 hijacks cholesterol trafficking to fuel infection and evade immune responses